Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity

被引:14
作者
Palamarchuk, A
Efanov, A
Maximov, V
Aqeilan, RI
Croce, CM
Pekarsky, Y
机构
[1] Ohio State Univ, Sch Med, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Sch Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
关键词
D O I
10.1158/0008-5472.CAN-05-0751
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The helix-loop-helix transcription factor Tall is required for blood cell development and its activation is a frequent event in T-cell acute lymphoblastic leukemia. The Akt (protein kinase B) kinase is a key player in transduction of antiapoptotic and proliferative signals in T cells. Because Tall has a putative Akt phosphorylation site at Thr90, we investigate whether Akt regulates Tall. Our results show that Akt specifically phosphorylates Thr90 of the Tall protein within its transactivation domain in vitro and in vivo. Coimmuno-precipitation experiments showed the presence of Tall in Akt immune complexes, suggesting that Tall and Akt physically interact. We further showed that phosphorylation of Tall by Akt causes redistribution of Tall within the nucleus. Using luciferase assay, we showed that phosphorylation of Tall by Akt decreased repressor activity of Tall on EpB42 (P4.2) promoter. Thus, these data indicate that Akt interacts with Tall and regulates Tall by phosphorylation at Thr90 in a phosphatidylinositol 3-kinase-dependent manner.
引用
收藏
页码:4515 / 4519
页数:5
相关论文
共 20 条
[1]  
AHMED NN, 1993, ONCOGENE, V8, P1957
[2]   Role of translocation in the activation and function of protein kinase B [J].
Andjelkovic, M ;
Alessi, DR ;
Meier, R ;
Fernandez, A ;
Lamb, NJC ;
Frech, M ;
Cron, P ;
Cohen, P ;
Lucocq, JM ;
Hemmings, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) :31515-31524
[3]  
Begley CG, 1999, BLOOD, V93, P2760
[4]   Akt activation by growth factors is a multiple-step process: the role of the PH domain [J].
Bellacosa, A ;
Chan, TO ;
Ahmed, NN ;
Datta, K ;
Malstrom, S ;
Stokoe, D ;
McCormick, F ;
Feng, JN ;
Tsichlis, P .
ONCOGENE, 1998, 17 (03) :313-325
[5]   AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation [J].
Chan, TO ;
Rittenhouse, SE ;
Tsichlis, PN .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :965-1014
[6]   Nucleolus and apoptosis [J].
Horky, M ;
Kotala, V ;
Anton, M ;
Wesierska-Gadek, J .
CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS, 2002, 973 :258-264
[7]   The protooncogene TCL1 is an Akt kinase coactivator [J].
Laine, J ;
Künstle, G ;
Obata, T ;
Sha, M ;
Noguchi, M .
MOLECULAR CELL, 2000, 6 (02) :395-407
[8]   Bad can act as a key regulator of T cell apoptosis and T cell development [J].
Mok, CL ;
Gil-Gómez, G ;
Williams, O ;
Coles, M ;
Taga, S ;
Tolaini, M ;
Norton, T ;
Kioussis, D ;
Brady, HJM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (03) :575-586
[9]   TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB [J].
O'Neil, J ;
Shank, J ;
Cusson, N ;
Murre, C ;
Kelliher, M .
CANCER CELL, 2004, 5 (06) :587-596
[10]   The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice [J].
O'Neil, J ;
Billa, M ;
Oikemus, S ;
Kelliher, M .
ONCOGENE, 2001, 20 (29) :3897-3905